XENETIC BIOSCIENCES, INC. (XBIO) Net margin 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-90.1%FY2025 · since FY2016: -1806.9% → -90.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -90.1% | +68.3 pp |
| FY2024 | -158.4% | +4.4 pp |
| FY2023 | -162.8% | +221.1 pp |
| FY2022 | -383.9% | +102.5 pp |
| FY2021 | -486.4% | +2006.8 pp |
| FY2020 | -2493.1% | +72363.5 pp |
| FY2019 | -74856.6% | — |
| FY2017 | -47.4% | +1759.5 pp |
| FY2016 | -1806.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIO financial trends
XBIO RevenueXBIO Net incomeXBIO Gross profitXBIO Gross marginXBIO Operating incomeXBIO Operating marginXBIO Operating cash flowXBIO Free cash flowXBIO Capital expendituresXBIO Return on equityXBIO Stock buybacksXBIO Dividends paidXBIO Total assetsXBIO Total liabilitiesXBIO Shareholders’ equityXBIO overview →